Search

everythinglearnresearchcommunity

for

Search:↓

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.

The guideline offers practical advice for diagnosing and treating Post-COVID/Long-COVID.

The guideline offers current advice for diagnosing and treating Long- and Post-COVID symptoms.

Low-dose oral minoxidil is safe and effective for treating hair loss, with most side effects being mild and reversible.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

ILC1-like cells can independently cause alopecia areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Accurate diagnosis and personalized treatment are crucial in dermatopathology.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Lower MC2R expression may contribute to alopecia areata.

γδTregs can protect hair follicles from alopecia areata and may help regrow hair.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Substance P may play a role in the inflammation seen in keratosis follicularis spinulosa decalvans.

Mutations in the ACTB gene cause Becker’s nevi and may lead to muscle issues in Becker’s nevus syndrome.

Quercetin effectively treated and prevented hair loss in mice.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Stem cells are key for hair follicle recovery.

Kv1.3 blockers may help treat alopecia areata and promote hair regrowth.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.